CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale EVP & Chief Strategy Officer sold 2,500 shares at $20.00 ($50,000)
- 4 Open-market sale EVP & Chief Financial Officer sold 24,000 shares at $20.00 ($480,000)
- 4 Open-market sale EVP & Chief Financial Officer sold 9,000 shares at $15.14 ($136,260)
- 4 Open-market sale Director sold 1,183 shares at $16.10 ($19,046)
- 4 Exercise or conversion EVP & Chief Financial Officer acquired 10,501 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,603 shares (option exercise)
- 4 Open-market sale EVP & Chief Strategy Officer sold 14,273 shares at an average $15.42 ($220,144)
- 4 Open-market sale EVP & Chief R & QA Officer sold 3,059 shares at $15.96 ($48,822)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 7,604 shares at $15.49 ($117,786)
- 4 Open-market sale Chief Executive Officer sold 4,800 shares at an average $15.56 ($74,664)
- 4 Open-market sale EVP & Chief Strategy Officer sold 6,274 shares at an average $15.47 ($97,029)
- 4 Open-market sale EVP, R&D & Chief Scientific Of sold 13,975 shares at $15.46 ($216,054)
- 4 Open-market sale EVP, General Counsel & Sec. sold 12,215 shares at an average $15.72 ($192,067)
- 4 Grant or award EVP, R&D & Chief Scientific Of acquired 49,500 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 49,500 shares (grant or award)
- 4 Grant or award EVP & Chief Strategy Officer acquired 45,000 shares (grant or award)
- 4 Grant or award EVP, General Counsel & Sec. acquired 49,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 165,000 shares (grant or award)
- 4 Grant or award EVP & Chief R & QA Officer acquired 49,500 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 4,800 shares at an average $13.66 ($65,568)
Page 23 of 33 · 645 filings